Table 2.

Studied characteristics

Characteristics	Oxytocin n = 100	Misoprostol n = 100	Methylergometrine n = 100	Significance
Third stage duration (min)	6.411 ± 1.589	6.128 ± 1.563	7.191 ± 3.545	Significant
Blood loss in third stage (ml)	118.60 ± 70.72	101.45 ± 56.24	189.50 ± 90.65	Significant
Need for additional uterotonics	3 %	1 %	7 %	Non significant
Side effects	S = 3  N = 1 H = 1	S = 23 F = 11  V = 1	N = 23  V = 10 S = 3 H.T. = 2	Significant
Third stage complications		PPH = 1	PPH = 1 Ret Placenta = 1	Non significant

S shivering, N nausea, V vomiting, H headache, F fever, HT hypertension